Independent Director name change to Dr Neeti Gupta after marriage

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹36.80

prior close

₹36.06

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-1.1% vs market

Pharmaceuticals peers, median of 168sector-0.2%-0.7% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

+2.4

15m

-0.2

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9+0.3-1.1-0.2-0.7

Next day

-1.0+1.1-2.1-0.2-0.7

-6.4+1.3-7.7-0.4-6.0

-4.9+2.0-6.9-0.7-4.2

-3.5+0.3-3.9-1.1-2.4

-3.5+1.1-4.6-0.8-2.7

-6.2-3.2-3.0-4.1-2.1

15d

-4.9-4.8-0.1-2.7-2.1

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sandu Pharmaceuticals informed BSE that Non-Executive Independent Director Dr Neeti Madan Kapre (DIN: 06801264) has changed her name to Dr Neeti Gupta following her marriage. There is no change in her designation, directorship, or DIN. The same person continues on the board under her new name.

Likely market impact

No impact on shareholders; purely an administrative name update with no change in board composition or governance.